Cancer Immunotherapy
Male birth control drug may hold promise for treating lung cancer, Chinese study finds
December 4, 2019Research and Development Cancer Immunotherapy, Chinese Pharmaceuticals, Male Birth Control, lung cancer
A drug for male birth control may hold promise for treating lung cancer patients when treatments like immunotherapy do not …
J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments
March 1, 2019Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology
Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …
Merck says US FDA to review its Keytruda for head & neck cancer
April 14, 2016Research and Development, Sales and Marketing Cancer Immunotherapy, Merck & Co, US FDA, keytruda
The US Food and Drug Administration has accepted Merck & Co’s (NYSE: MRK) supplemental biologics license application (sBLA) for its immunotherapy cancer …
Celyad teams-up with Institut Curie to advance its immuno-oncology program
March 22, 2016Manufacturing and Production, Research and Development Cancer Immunotherapy, Celyad, Institut Curie, cellular immunotherapies
Celyad (Nasdaq: CYAD) on Tuesday said it has partnered with Institut Curie to develop its NKR-T pipeline in cellular immunotherapies …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
